Company: IMRX
Filing Date: 2025-09-08
Form Type: 424B3
Source: 0001104659-25-088317
Chunk: 24

Company: Immuneering Corp
Filing Date: 2025-09-08
Form: 424B3
Chunk 24
---
 donees, pledgees, transferees or other successors in interest selling securities received after the date of this prospectus from a Selling Stockholder as a gift, pledge, partnership distribution or other transfer. We are registering the shares in order to permit the Selling Stockholders to offer the shares for resale from time to time. Except for the ownership of the Company’s securities or as otherwise disclosed in this prospectus, the Selling Stockholders have not had any material relationship with us within the past three years.

The following table sets forth information concerning the shares of Common Stock that may be offered from time to time by each Selling Stockholder. The number of shares beneficially owned by each Selling Stockholder is determined under rules issued by the SEC. Under these rules, beneficial ownership includes any shares as to which the Selling Stockholder has sole or shared voting power or investment power. Percentage ownership is based on 41,570,226 shares of Common Stock outstanding as of September 2, 2025. In computing the number of shares beneficially owned by a selling securityholder and their percentage ownership, shares of Common Stock subject to options, warrants or other rights held by such Selling Stockholder that are currently exercisable or will become exercisable within 60 days of September 2, 2025 are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage ownership of any other Selling Stockholder. Each of the Selling Stockholders listed has sole voting and investment power with respect to the shares beneficially owned by the selling securityholder unless noted otherwise.

The information in the following table has been provided to us by or on behalf of the Selling Stockholders and the Selling Stockholders may have sold, transferred or otherwise disposed of all or a portion of their securities or acquired additional securities after the date on which they provided us with information regarding their securities. A Selling Stockholder may sell all, some or none of its securities in this offering. See “Plan of Distribution.”

The second column lists the total number of shares of Class A common stock beneficially owned by each Selling Stockholder, based on its ownership of the Class A common stock, as of September 2, 2025. The fourth column lists the Common Stock being offered by this prospectus by the Selling Stockholders. In accordance with the terms of a registration rights agreement with the Selling Stockholders, this prospectus generally covers the resale of the sum of (i) the number of shares of Common Stock issued to the Selling Stockholders in the “Private Placement of Securities” described